AU2011903754A0 - Combination therapy to reduce the risk of and to treat cancer - Google Patents

Combination therapy to reduce the risk of and to treat cancer

Info

Publication number
AU2011903754A0
AU2011903754A0 AU2011903754A AU2011903754A AU2011903754A0 AU 2011903754 A0 AU2011903754 A0 AU 2011903754A0 AU 2011903754 A AU2011903754 A AU 2011903754A AU 2011903754 A AU2011903754 A AU 2011903754A AU 2011903754 A0 AU2011903754 A0 AU 2011903754A0
Authority
AU
Australia
Prior art keywords
risk
reduce
combination therapy
treat cancer
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011903754A
Inventor
Paul Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EaglePharma Pty Ltd
Original Assignee
EaglePharma Pty Ltd
Filing date
Publication date
Application filed by EaglePharma Pty Ltd filed Critical EaglePharma Pty Ltd
Publication of AU2011903754A0 publication Critical patent/AU2011903754A0/en
Abandoned legal-status Critical Current

Links

AU2011903754A 2011-09-13 Combination therapy to reduce the risk of and to treat cancer Abandoned AU2011903754A0 (en)

Publications (1)

Publication Number Publication Date
AU2011903754A0 true AU2011903754A0 (en) 2011-09-29

Family

ID=

Similar Documents

Publication Publication Date Title
HRP20190046T1 (en) Combination therapy for the treatment of cancer
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
HK1202253A1 (en) Combination treatment of cancer
EP2688594A4 (en) Methods and compositions for the treatment of cancer
EP2788378A4 (en) Combination therapy for treatment of cancer
EP2830633A4 (en) Combination therapy for the treatment of cancer
ZA201300762B (en) Novel combination therapy for the treatment of cancer
IL275636A (en) Therapeutic combination for the treatment of cancer
HUE037382T2 (en) Methods of treating cancer comprising targeting nqo1
HK1203430A1 (en) Bisarylsulfonamides useful in the treatment of inflammation and cancer
IL236321A0 (en) Combination therapy for the treatment of cancer and immunosuppression
EP2744786A4 (en) Substituted 2-imidazolidinones and 2-imidazolones and their use in the treatment of cancer
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
AU2011903754A0 (en) Combination therapy to reduce the risk of and to treat cancer
WO2012106461A9 (en) Combination therapy for treatment of cancer
AU2012904010A0 (en) Combination therapy to reduce the risk of and to treat cancer
IL233495A0 (en) Combination therapy for the treatment of cancer
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment
AU2011904831A0 (en) Apricitabine and PI combination therapy
AU2010904107A0 (en) Treatment of cancer
AU2011902129A0 (en) Compositions for Therapy and Methods of Treatment
AU2012904722A0 (en) Agents for cancer therapy or prophylaxis and uses therefor
GB201121791D0 (en) Combination treatment of cancer
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer
AU2010904813A0 (en) Skin cancer prevention and treatment